Price of cancer drugs varies by up to 388% between European countries, Australia, and New Zealand

The price of new cancer drugs varies widely (from 28% to 388%) between high-income countries in Europe, Australia, and New Zealand, new research has found. The UK and Mediterranean countries such as Greece, Spain, and Portugal pay the lowest average unit manufacturer prices for a group of 31 originator cancer drugs (new drugs under patent), whereas Sweden, Switzerland, and Germany pay the highest prices, say authors of a new report.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1XFGRDT